Top News
Latest News
PARTNERSHIPS
20 Aug 2025
Inside AbbVie's High-Stakes Deal on Next-Gen mRNA TherapyRESEARCH
14 Aug 2025
Early Cancer Trial Puts mRNA in the SpotlightINVESTMENT
9 Aug 2025
mRNA's Next Act: Strand Secures $153M for Cancer FightINSIGHTS
6 Aug 2025
The Rare-Disease Frontier Where mRNA Is Headed
Smarter, Faster, Cheaper: Al Reinvents mRNA Discovery
TECHNOLOGY
29 Jul 2025
UT Austin and Sanofi unveil RiboNN, an Al that speeds mRNA drug development and raises early-stage success rates.
PARTNERSHIPS
20 Aug 2025
Inside AbbVie's High-Stakes Deal on Next-Gen mRNA Therapy
AbbVie's Capstan buy signals a bold leap into in-vivo mRNA therapies, reshaping the race for next-gen autoimmune treatments.
RESEARCH
14 Aug 2025
Early Cancer Trial Puts mRNA in the Spotlight
Strand's STX-001 shows early tumor-fighting promise as mRNA shifts from vaccines to therapeutics.
INVESTMENT
9 Aug 2025
mRNA's Next Act: Strand Secures $153M for Cancer Fight
Boston biotech secures major funding as investors back oncology applications of mRNA
INSIGHTS
6 Aug 2025
The Rare-Disease Frontier Where mRNA Is Headed
Acuitas pioneers gene-editing delivery for rare disease, signaling mRNA's evolution beyond vaccines.
TECHNOLOGY
29 Jul 2025
Smarter, Faster, Cheaper: Al Reinvents mRNA Discovery
UT Austin and Sanofi unveil RiboNN, an Al that speeds mRNA drug development and raises early-stage success rates.
INNOVATION
25 Jul 2025
RNA Therapy Makes CAR-T in the Body a Reality
Orbital's circular RNA reprograms CAR-T cells in vivo, cutting costs and widening access for autoimmune and cancer care.
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.